methyldopa has been researched along with Abruptio Placentae in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellos, I; Daskalakis, G; Loutradis, D; Papapanagiotou, A; Pergialiotis, V | 1 |
| Adam, I; Elhassan, EM; Habour, AB; Mirghani, OA | 1 |
1 review(s) available for methyldopa and Abruptio Placentae
| Article | Year |
|---|---|
Comparative efficacy and safety of oral antihypertensive agents in pregnant women with chronic hypertension: a network metaanalysis.
Topics: Abruptio Placentae; Amlodipine; Antihypertensive Agents; Atenolol; Cesarean Section; Chronic Disease; Female; Fetal Growth Retardation; Furosemide; Gestational Age; Humans; Hypertension; Incidence; Infant, Small for Gestational Age; Ketanserin; Methyldopa; Network Meta-Analysis; Nifedipine; Perinatal Death; Pindolol; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Premature Birth; Severity of Illness Index | 2020 |
1 trial(s) available for methyldopa and Abruptio Placentae
| Article | Year |
|---|---|
Methyldopa versus no drug treatment in the management of mild pre-eclampsia.
Topics: Abruptio Placentae; Adult; Antihypertensive Agents; Apgar Score; Birth Weight; Delivery, Obstetric; Disease Progression; Eclampsia; Female; Fetal Death; Fetal Growth Retardation; Humans; Methyldopa; Organ Size; Parity; Pediatrics; Placenta; Pre-Eclampsia; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, Third; Referral and Consultation; Severity of Illness Index; Treatment Outcome | 2002 |